These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 6735994

  • 1. New contributions from basic science to understanding the effects of monoamine oxidase inhibiting antidepressants.
    Murphy DL, Garrick NA, Aulakh CS, Cohen RM.
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):37-43. PubMed ID: 6735994
    [Abstract] [Full Text] [Related]

  • 2. Studies of selective and reversible monoamine oxidase inhibitors.
    Mann JJ, Aarons SF, Frances AJ, Brown RD.
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):62-6. PubMed ID: 6429130
    [Abstract] [Full Text] [Related]

  • 3. [Effect of benzamide derivatives on rat brain monoamine oxidase activity in vitro].
    Gol'dina OA, Zagorevskiĭ VA, Lopatina KI, Sokolova TV, Gankina EM.
    Biull Eksp Biol Med; 1986 Aug; 102(8):170-2. PubMed ID: 3742029
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB, Weinstock M.
    Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
    [Abstract] [Full Text] [Related]

  • 5. [Properties of intestinal monoamine oxidase in the rat].
    Verevkina IV, Asnina VV, Gorkin VZ.
    Vopr Med Khim; 1982 Jan; 28(2):88-93. PubMed ID: 7080482
    [Abstract] [Full Text] [Related]

  • 6. [Effect of various antidepressive agents on brain monoamine oxidase activity].
    Gankina EM, Moskvitina TA, Gorkin VZ, Val'dman AV.
    Biull Eksp Biol Med; 1982 Nov; 94(11):29-31. PubMed ID: 7150732
    [Abstract] [Full Text] [Related]

  • 7. Elucidating the mechanism of action and potential interactions of MAO-B inhibitors.
    Bainbridge JL, Page RL, Ruscin JM.
    Neurol Clin; 2008 Aug; 26(3 Suppl):S85-96, vi. PubMed ID: 18774444
    [Abstract] [Full Text] [Related]

  • 8. [Monoamine oxidase inhibitors and pressor response to dietary amines].
    Tipton KF.
    Vopr Med Khim; 1997 Aug; 43(6):494-503. PubMed ID: 9503566
    [Abstract] [Full Text] [Related]

  • 9. [Baygon (2-isopropoxyphenyl-N-methyl carbamate) activation of enzymatic deamination of 2-phenyl-ethylamine].
    Zeĭnalov TA.
    Vopr Med Khim; 1985 Aug; 31(5):60-4. PubMed ID: 4090367
    [Abstract] [Full Text] [Related]

  • 10. [Selective inhibition of type A monoamine oxidase by pyrazidol].
    Mashkovskiĭ MD, Gorkin VZ, Verevkina IV, Asnina VV, Tupikina SM.
    Biull Eksp Biol Med; 1981 Feb; 91(2):169-71. PubMed ID: 7225552
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of monoamine oxidase type A, but not type B, is an effective means of inducing anticonvulsant activity in the kindling model of epilepsy.
    Löscher W, Lehmann H, Teschendorf HJ, Traut M, Gross G.
    J Pharmacol Exp Ther; 1999 Mar; 288(3):984-92. PubMed ID: 10027835
    [Abstract] [Full Text] [Related]

  • 12. Tyramine and new monoamine oxidase inhibitor drugs.
    Simpson GM, de Leon J.
    Br J Psychiatry Suppl; 1989 Oct; (6):32-7. PubMed ID: 2695125
    [Abstract] [Full Text] [Related]

  • 13. Effect of lamotrigine on the activities of monoamine oxidases A and B in vitro and on monoamine disposition in vivo.
    Southam E, Pereira R, Stratton SC, Sargent R, Ford AJ, Butterfield LJ, Wheable JD, Beckett SR, Roe C, Marsden CA, Hagan RM.
    Eur J Pharmacol; 2005 Sep 20; 519(3):237-45. PubMed ID: 16129425
    [Abstract] [Full Text] [Related]

  • 14. Clinical and laboratory studies with selective monoamine-oxidase-inhibiting drugs. Implications for hypothesized neurotransmitter changes associated with depression and antidepressant drug effects.
    Murphy DL, Cohen RM, Siever LJ, Roy B, Karoum F, Wyatt RJ, Garrick NA, Linnoila M.
    Mod Probl Pharmacopsychiatry; 1983 Sep 20; 19():287-303. PubMed ID: 6408411
    [No Abstract] [Full Text] [Related]

  • 15. Monoamine oxidase inhibitors--current status.
    Zemishlany Z, Radwan M, Wijsenbeek H.
    Isr J Psychiatry Relat Sci; 1983 Sep 20; 20(3):254-71. PubMed ID: 6325369
    [No Abstract] [Full Text] [Related]

  • 16. Clinical pharmacology of reversible monoamine oxidase-A inhibitors.
    Bieck PR, Antonin KH, Schmidt E.
    Clin Neuropharmacol; 1993 Sep 20; 16 Suppl 2():S34-41. PubMed ID: 8313395
    [Abstract] [Full Text] [Related]

  • 17. Reversible monoamine oxidase-A inhibitors in resistant major depression.
    Nolen WA, Hoencamp E, Bouvy PF, Haffmans PM.
    Clin Neuropharmacol; 1993 Sep 20; 16 Suppl 2():S69-76. PubMed ID: 8313400
    [Abstract] [Full Text] [Related]

  • 18. [Inhibitory monoamine oxidases of the new generation].
    Nowakowska E, Chodera A.
    Pol Merkur Lekarski; 1997 Jul 20; 3(13):1-4. PubMed ID: 9432289
    [Abstract] [Full Text] [Related]

  • 19. Differential response patterns to MAO inhibitors and tricyclics.
    Nies A.
    J Clin Psychiatry; 1984 Jul 20; 45(7 Pt 2):70-7. PubMed ID: 6376487
    [Abstract] [Full Text] [Related]

  • 20. Monoamine oxidase. Its inhibition.
    Youdim MB.
    Mod Probl Pharmacopsychiatry; 1975 Jul 20; 10():65-88. PubMed ID: 1101049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.